Stacy Lindborg

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Lawrenceville, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Stacy Lindborg

Form 4 holding President and CEO, Director

Imunon, Inc.

Security class
Common Stock
Shares / value
86,639
Estimated value
$163,747
Report date
31 Jul 2026
Price
$1.89
Ownership
Direct
Form 4 holding President and CEO, Director

Imunon, Inc.

Security class
Common Stock
Shares / value
778
Estimated value
$1,470
Report date
31 Jul 2026
Price
$1.89
Ownership
By 401(k) Plan
Form 4 holding President and CEO, Director

Imunon, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
56,187
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Imunon, Inc.

Security class
Restricted Stock
Shares / value
0
Estimated value
Report date
06 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Stacy Lindborg

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .